Type I Plasminogen Deficiency
Also known as: Hypoplasminogenemia / Plasminogen deficiency / Hypoplasminogenemia (disorder)
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB16701 | Plasminogen | Plasma-derived human plasminogen administered intravenously to treat type 1 plasminogen deficiency (hypoplasminogenemia). |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB16701 | Plasminogen | Tissue-type plasminogen activator | enzyme |
| DB16701 | Plasminogen | Urokinase-type plasminogen activator | enzyme |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB16701 | Plasminogen | 1 | Completed | 1 |
| DB16701 | Plasminogen | 2 / 3 | Completed | 1 |
| DB16701 | Plasminogen | Not Available | No Longer Available | 2 |